
Sign up to save your podcasts
Or


Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care.
Show reference:
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316
By American Academy of Neurology4.8
129129 ratings
Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care.
Show reference:
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316

497 Listeners

294 Listeners

51 Listeners

288 Listeners

3,337 Listeners

260 Listeners

13 Listeners

22 Listeners

194 Listeners

513 Listeners

366 Listeners

6,357 Listeners

181 Listeners

370 Listeners

79 Listeners